Deadline: 26-Oct-20
The Health Resources and Services Administration (HRSA) is accepting applications for the fiscal year (FY) 2021 AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF).
The purpose of this program is to provide funding to states/territories to prevent, reduce, or eliminate ADAP waiting lists, including through cost-containment measures. Section 311 of Title III of the Public Health Service (PHS) Act authorizes the Secretary to utilize resources to control epidemics of any disease. These funds are to be used in conjunction with the Ryan White HIV/AIDS Program (RWHAP) Part B ADAP administered by the HRSA, HIV/AIDS Bureau (HAB), Division of State HIV/AIDS Programs (DSHAP).
To ensure that RWHAP aligns with the National HIV/AIDS Strategy, to the extent possible, activities funded by the program focus on addressing the plan’s four goals:
- Reduce new HIV infections;
- Increase access to care and improve health outcomes for people with HIV;
- Reduce HIV-related health disparities and health inequities; and
- Achieve a more coordinated national response.
To achieve these shared goals, recipients should align their organization’s efforts, within the parameters of the RWHAP statute and program guidance, to ensure that people with HIV are linked to and retained in care, and have timely access to HIV treatment and the support services needed (e.g., mental health and substance use disorders services) to achieve HIV viral suppression. The RWHAP also provides technical assistance and training initiatives and promotes the effective use of data to enhance recipients’ capacity to implement programs that support the strategy’s objectives.
Funding Information
- HRSA estimates approximately $75,000,000 to be available annually to fund up to 30 recipients. You may apply for a ceiling amount of up to $7,000,000 total cost (includes both direct and indirect, facilities and administrative costs) per year. The actual amount available will not be determined until the enactment of the final FY 2021 federal appropriation.
- This program notice is subject to the appropriation of funds and is a contingency action taken to ensure that, should funds become available for this purpose, HRSA can process applications and award funds appropriately. The period of performance is April 1, 2021, through March 31, 2022 (1 year).
Eligibility Criteria
Eligible applicants are limited to RWHAP Part B states/territories that:
- reported to HRSA a current ADAP waiting list,
- have used the ADAP ERF to prevent, reduce, or eliminate an ADAP waiting list between January 2011 and July 2020,
- need additional funding for a projected increase in treatment needs aligned with ending the HIV epidemic, or
- need additional funding for other unanticipated increases in the number of clients in the program due to new diagnosis, re-engagement in care, client loss of income, and/or client loss of health care coverage.
- All 50 States, the District of Columbia, the Commonwealth of Puerto Rico, the U.S. Virgin Islands, Guam, American Samoa, the Commonwealth of the Northern Mariana Islands, the Republic of Palau, the Federated States of Micronesia, and the Republic of the Marshall Islands are eligible to apply for funding if they meet the above requirements.
For more information, visit https://www.grants.gov/web/grants/view-opportunity.html?oppId=328379